Financial Performance - In Q3 2024, the company achieved a revenue of 2.085 billion CNY, a year-on-year decrease of 3.02% and a quarter-on-quarter increase of 0.85% [1] - The net profit attributable to the parent company, excluding non-recurring items, was 275 million CNY, representing a year-on-year increase of 3.61% and a quarter-on-quarter increase of 11.38% [1] - For the first three quarters of 2024, total revenue reached 5.667 billion CNY, a year-on-year increase of 1.51%, while the net profit attributable to the parent company was 706 million CNY, down 5.16% year-on-year [1] Market Dynamics - The company faced intense competition in the battery chemical products sector, leading to a continuous decline in product prices [1] - Despite increased shipment volumes, the overall gross margin was affected by intensified domestic market competition and declining sales prices [1] - The company is actively responding to changes in supply and demand by stabilizing market share, strengthening strategic customer collaborations, and expanding international markets [1] Product Development and Outlook - The organic fluorine chemical products and capacitor chemical products are expected to maintain stable growth due to leading technology [2] - The company is optimistic about the future of its fluorinated liquid products, which are widely applicable in various industries, including semiconductors and new energy vehicles [2] - The company has secured stable orders from existing customers and anticipates further growth as new production lines come online [3] International Expansion - The company began delivering lithium-ion battery electrolyte products to U.S. customers from its Poland factory in the second half of 2024, with stable customer orders [3] - The Poland factory has a production capacity of 40,000 tons per year, effectively meeting the demands of both European and U.S. markets [3] - The company has signed long-term supply agreements with numerous well-known overseas battery customers, with disclosed overseas order amounts reaching approximately 3.2 billion USD [3] Challenges and Strategic Responses - The overseas new energy vehicle market faces challenges such as local market development barriers and regulatory hurdles [4] - The company believes in the significant growth potential of the overseas market but acknowledges the need for time and strategic investment to ensure long-term competitiveness [4] - Management expenses decreased in Q3 2024 primarily due to performance-related expense accruals, while the overall gross margin slightly declined due to lower margins on high-volume electrolyte products [4]

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company reported a significant quarter-on-quarter increase in performance for Q3 2024, with a total revenue of 20.8 billion yuan, a year-on-year decrease of 3.0% but a quarter-on-quarter increase of 0.9% [1] - The organic fluorine segment continues to grow, with stable demand for first-generation pharmaceutical intermediates and a robust production capacity for second-generation products [2] - The electrolytic solution industry is experiencing a slight decline in profitability, but the company’s overseas projects are progressing well, with a successful launch of a 40,000-ton electrolytic solution project in Poland [3] Financial Performance Summary - For the first three quarters of 2024, the company achieved a revenue of 56.7 billion yuan, a year-on-year increase of 1.5%, while the net profit attributable to shareholders was 7.0 billion yuan, a year-on-year decrease of 12% [1] - The Q3 single-quarter gross margin was 25.7%, down 2.5 percentage points year-on-year, while the net profit margin was 13.8%, up 0.6 percentage points year-on-year [1] - The company’s projected net profits for 2024-2026 are estimated at 10.8 billion yuan, 15.1 billion yuan, and 19.0 billion yuan, respectively, with corresponding P/E ratios of 28.2, 20.2, and 16.0 [3][4] Industry Insights - The demand for fluorinated chemical products is expected to grow, particularly for second and third-generation products, as major overseas competitors exit the market [2] - The consumer electronics sector is seeing an uptick in demand, with global smartphone shipments increasing by 5% year-on-year in Q3 2024, benefiting the company’s capacitor and semiconductor chemicals [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has shown growth in Q3 2024, with a year-on-year revenue increase of 1.51% to 56.67 billion yuan and a net profit of 7.01 billion yuan, although the net profit excluding non-recurring items decreased by 5.16% [1] - The performance in Q3 2024 indicates a recovery with a net profit of 2.86 billion yuan, up 1.89% year-on-year and 13.91% quarter-on-quarter, primarily driven by the growth in the fluorochemical business [1] - The company is expected to benefit from the overseas expansion of its electrolyte products, which may enhance profitability despite ongoing price pressures in the domestic market [1] Financial Performance Summary - For Q3 2024, total revenue was 20.85 billion yuan, a decrease of 3.02% year-on-year but an increase of 0.85% quarter-on-quarter [1] - The average price of domestic electrolytes in Q3 2024 was 18,700 yuan per ton, down 41.7% year-on-year and 11.9% quarter-on-quarter, impacting the company's profitability [1] - The company anticipates a recovery in profitability as it expands its overseas operations and continues to develop its fluorochemical product lines [1] Future Outlook - The company is projected to achieve net profits of 11.04 billion yuan, 15.65 billion yuan, and 20.00 billion yuan for the years 2024, 2025, and 2026 respectively, with corresponding P/E ratios of 28X, 19X, and 15X [1] - The ongoing construction of production bases and the expansion of high-end fluorochemical projects are expected to support long-term growth and market share improvement [1]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - Q3 performance met expectations with total revenue of 5.67 billion yuan, a year-on-year increase of 1.5%, and a net profit of 700 million yuan, a year-on-year decrease of 12.0% [2] - The company expects a significant increase in shipments in Q4, particularly in the U.S. market, which is anticipated to enhance profitability [3] - The fluorochemical segment showed a sequential profit increase in Q3, with expected contributions from capacitors and semiconductor chemicals also showing steady growth [3] - The company has effectively controlled expenses, with a decrease in the expense ratio and a slight increase in inventory [4] - The profit forecast for 2024-2026 is set at 10.65 billion, 14.42 billion, and 20.12 billion yuan respectively, with corresponding P/E ratios of 29, 21, and 15 [4] Summary by Sections Financial Performance - For Q3, the company reported revenue of 2.08 billion yuan, with a year-on-year decrease of 3.0% and a quarter-on-quarter increase of 0.8%. The net profit for Q3 was 290 million yuan, reflecting a quarter-on-quarter increase of 1.9% and a year-on-year increase of 13.9% [2] - The gross margin for Q3 was 25.7%, down 2.5 percentage points quarter-on-quarter, while the net profit margin was 13.7%, up 0.7 percentage points quarter-on-quarter [2] Shipment and Market Outlook - The company expects to ship approximately 135,000 tons of electrolyte in the first three quarters of 2024, a year-on-year increase of over 40%, with Q3 shipments reaching over 56,000 tons, a year-on-year increase of over 30% [3] - The company anticipates that shipments will stabilize in Q4, with total shipments for the year projected to be between 190,000 and 200,000 tons, representing a year-on-year increase of about 50% [3] Profitability and Expense Management - The fluorochemical segment is expected to contribute over 200 million yuan in profit for Q3, with a sequential increase of 7% [3] - The company reported a decrease in total expenses to 690 million yuan for the first three quarters of 2024, down 4.8% year-on-year, with a significant reduction in Q3 expenses [4] Valuation and Price Target - The target price for the company is set at 57 yuan, based on a projected P/E ratio of 30x for 2025, reflecting strong competitive advantages in the fluorochemical sector and a recovery in electrolyte pricing [4]

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-078 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于变更公司经营范围并修订《公司章程》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）于2024年10月25日召开 第六届董事会第十五次会议、第六届监事会第十四次会议，审议通过了《关于变 更公司经营范围并修订<公司章程>的议案》，现将有关事项公告如下： 一、公司经营范围变更情况 根据公司经营发展需要，公司拟对经营范围进行增项，具体变更情况如下： | 变更前 | 变更后 | | --- | --- | | 经依法登记，公司的经营范围：铝电解 | 经依法登记，公司的经营范围：铝电解 | | 电容器、锂离子二级电池专用电子化 | 电容器、锂离子二级电池专用电子化 | | 学材料的开发和产销（以上不含限制 | 学材料的开发和产销（以上不含限制 | | 项目）；经营进出口业务（按深贸管登 | 项目）；经营进 ...

2024 年 10 月 | 第一章 | 总则 | ·············································································································· | 3 | | --- | --- | --- | --- | | 第二章 | 经营宗旨和范围 | ······························································································· | 3 | | 第三章 | 股份 | ·············································································································· | 4 | | 第一节 | 股份发行 | ··············································································· ...

深圳新宙邦科技股份有限公司 董事、监事和高级管理人员所持本公司股份及其变动管理制度 深圳新宙邦科技股份有限公司 董事、监事和高级管理人员所持本公司股份及其变动管理制度 第一章 总则 第一条 为规范公司董事、监事和高级管理人员所持本公司股份及其变动的 的管理，根据《公司法》《证券法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《上市公司股东减持股份管理暂行办法》《上市 公司董事、监事和高级管理人员所持本公司股份及其变动管理规则》《深圳证券 交易所上市公司自律监管指引第 10 号——股份变动管理》和《深圳证券交易所 上市公司自律监管指引第 18 号——股东及董事、监事、高级管理人员减持股份》 等法律法规以及《公司章程》的相关规定，制定本制度。 第二条 公司董事、监事和高级管理人员应当遵守本制度，其所持本公司股 份是指登记在其名下的所有本公司股份。公司董事、监事、高级管理人员不得进 行以本公司股票为标的证券的融资融券交易。 第三条 公司董事、监事和高级管理人员在买卖本公司股票及其衍生品种前， 应当知悉《公司法》《证券法》等法律、法规以及其他相关规定中关于内幕交易、 操纵市场、短线交易等 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-079 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于召开2024年第四次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 3、会议召开的合法、合规性：公司于2024年10月25日召开的第六届董事会 第十五次会议审议通过了《关于召开2024年第四次临时股东大会的议案》，本 次会议的召开程序符合有关法律法规要求以及《公司章程》的规定。 4、会议召开的日期、时间 （1）现场会议召开时间：2024年11月14日（星期四）14:00 （2）网络投票时间： 深圳新宙邦科技股份有限公司（以下简称"公司"）第六届董事会第十五次 会议决议决定于2024年11月14日（星期四）在深圳市坪山区新宙邦科技大厦16层 会议室召开2024年第四次临时股东大会。 现将本次会议有关事项通知如下： 一、召开会议基本情况 1、股东大会届次：2024年第四次临时股东大会 2、会议召集人：公司第六届董事会 通过深圳证券 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-074 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 第六届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 公司第六届董事会审计委员会审议通过了该议案中的财务报告部分。 表决结果：9 票同意，0 票反对，0 票弃权，获得通过。 二、审议通过了《关于<公司 2024 年第三季度安全生产专题报告>的议案》 董事会审议了公司 EHS 中心提交的《公司 2024 年第三季度安全生产专题报 告》，讨论并同意公司 2024 年第三季度安全生产工作总结及 2024 年第四季度 EHS 重点工作和目标，全面落实企业安全生产主体责任有关事项。 表决结果：9 票同意，0 票反对，0 票弃权，获得通过。 1 三、审议通过了《关于修订<董事、监事和高级管理人员所持本公司股份及 其变动管理制度>的议案》 深圳新宙邦科技股份有限公司（以下简称"公司"）第六届董事会第十五次 会议于2024年10月25日以 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-075 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 一、审议通过了《关于<公司 2024 年第三季度报告>的议案》 经审核，公司监事会认为：董事会编制和审核《公司 2024 年第三季度报告》 的程序符合法律、行政法规和中国证监会的规定，《公司 2024 年第三季度报告》 真实、准确、完整的反映了公司 2024 年第三季度的实际经营情况，不存在任何 虚假记载、误导性陈述或者重大遗漏。 《公司 2024 年第三季度报告》具体内容详见同日刊登在中国证监会指定的创 业板信息披露网站巨潮资讯网。 表决结果：3 票同意，0 票反对，0 票弃权，获得通过。 二、审议通过了《关于变更公司经营范围并修订<公司章程>的议案》 第六届监事会第十四次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）第六届监事会第十四次 会议于2024年10月25日以通讯方式召开。本次 ...